|
Delayed
NSE India S.E.
05:57:39 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 3,001.00 INR | +5.52% |
|
+7.94% | +29.23% |
| 09-16 | RPG Life Sciences Limited - Shareholder/Analyst Call | |
| 08-14 | RPG Life Sciences Limited Announces Cessation of Deepak Shukla from Chief Executive - API Business, Effective August 14, 2026 | CI |
| Market Cap | 47.04B 494M 443M 410M 371M 693M 702M 4.9B 1.95B 24.61B 1.85B 1.81B 78.14B | P/E 2027 * |
36.9x | P/E 2028 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise Value | 47.04B 494M 443M 410M 371M 693M 702M 4.9B 1.95B 24.61B 1.85B 1.81B 78.14B | EV / Sales 2027 * |
5.48x | EV / Sales 2028 * | 4.68x |
| Free-Float |
22.59% | Yield 2027 * |
0.54% | Yield 2028 * | 0.66% |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| RPGLIFE | Delayed | |
Bombay S.E.
| RPGLIFE | Delayed |
Last Transcript: RPG Life Sciences Limited
| 1 day | +5.52% | ||
| 1 week | +7.94% | ||
| Current month | -1.19% | ||
| 1 month | -2.86% | ||
| 3 months | +5.29% | ||
| 6 months | +47.80% | ||
| Current year | +29.23% |
| 1 week | 2,558 |  | 3,050 |
| 1 month | 2,558 | | 3,112.8 |
| Current year | 1,733 | | 3,127.8 |
| 1 year | 1,733 | | 3,127.8 |
| 3 years | 1,292 | | 3,127.8 |
| 5 years | 450.55 | | 3,127.8 |
| 10 years | 142.95 | | 3,127.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ashok Nair
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | 2025-12-14 | |
| Compliance Officer | - | 2011-11-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 2008-02-05 | |
| Director/Board Member | 57 | 2015-01-22 | |
| Director/Board Member | 68 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/12/25 | Nucleus Life Trust
| Buy | Company | 3,048 | 0.0184% | |
| 3/12/25 | Nucleus Life Trust
| Buy | Company | 1,859 | 0.0112% | |
| 3/12/25 | Nucleus Life Trust
| Buy | Company | 4,412 | 0.0267% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.52% | +7.94% | +22.84% | +116.48% | 494M | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| +0.58% | +2.12% | +53.76% | +65.93% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +2.57% | +2.51% | +34.13% | +56.11% | 294B | |
| +0.99% | -0.74% | +2.58% | +26.09% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +1.63% | +1.42% | +39.28% | +80.42% | 403.77B | |
| Weighted average by Cap. | +1.16% | +1.50% | +44.85% | +89.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 8.58B 90.11M 80.85M 74.75M 67.69M 126M 128M 894M 356M 4.49B 338M 331M 14.26B | 10.04B 105M 94.6M 87.46M 79.21M 148M 150M 1.05B 417M 5.25B 396M 387M 16.68B |
| Net income | 1.33B 13.93M 12.5M 11.56M 10.47M 19.56M 19.79M 138M 55.04M 694M 52.29M 51.18M 2.2B | 1.66B 17.41M 15.62M 14.44M 13.08M 24.43M 24.73M 173M 68.77M 868M 65.33M 63.95M 2.75B |
| Net Debt | - | - |
Employees
1,366
Sector
Pharmaceuticals
Calendar
02:38am
Earnings release - Q2 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | ₹3,001.00 | +5.52% | 134,808 |
| 26-10-28 | ₹2,844.00 | +0.28% | 5,997 |
| 26-10-27 | ₹2,836.10 | +2.69% | 10,776 |
| 26-10-26 | ₹2,761.70 | +5.42% | 25,766 |
| 26-10-23 | ₹2,619.60 | -5.78% | 19,531 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RPGLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
